Reuters logo
BRIEF-Pharming FY net loss widens
March 7, 2013 / 6:07 AM / 5 years ago

BRIEF-Pharming FY net loss widens

BRUSSELS, March 7 (Reuters) - Pharming Group NV : * Total net loss from continuing operations increased to EUR 24.1 million

(2011: EUR 17.8 million) * Revenues and other income increased to EUR 10.9 million (2011: EUR 3.2

million) * Cash at the end of 2012 increased to EUR 6.3 million (2011: EUR 5.1 million)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below